Simi MBA - CardioComm Solutions Independent Director

EKGGF Stock  USD 0.01  0.00  0.00%   

Insider

Simi MBA is Independent Director of CardioComm Solutions
Phone416 977 9425
Webhttps://www.cardiocommsolutions.com

CardioComm Solutions Management Efficiency

The company has return on total asset (ROA) of 0.164 % which means that it generated a profit of $0.164 on every $100 spent on assets. This is way below average. CardioComm Solutions' management efficiency ratios could be used to measure how well CardioComm Solutions manages its routine affairs as well as how well it operates its assets and liabilities.
CardioComm Solutions has accumulated 413.81 K in total debt with debt to equity ratio (D/E) of 430.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. CardioComm Solutions has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist CardioComm Solutions until it has trouble settling it off, either with new capital or with free cash flow. So, CardioComm Solutions' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CardioComm Solutions sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CardioComm to invest in growth at high rates of return. When we think about CardioComm Solutions' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 9 records

INSIDER Age

Chris EdgarCogstate Limited
N/A
Rachel ColiteCogstate Limited
N/A
Benjamin BloomfieldCogstate Limited
N/A
Kenneth BillardCogstate Limited
N/A
BEc BEcCogstate Limited
52
Amy VeroffCogstate Limited
N/A
Darren WatsonCogstate Limited
N/A
BBus CACogstate Limited
N/A
Pr BBScCogstate Limited
N/A
CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada. Cardiocom Solutions operates under Health Information Services classification in the United States and is traded on OTC Exchange. CardioComm Solutions [EKGGF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

CardioComm Solutions Management Team

Elected by the shareholders, the CardioComm Solutions' board of directors comprises two types of representatives: CardioComm Solutions inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CardioComm. The board's role is to monitor CardioComm Solutions' management team and ensure that shareholders' interests are well served. CardioComm Solutions' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CardioComm Solutions' outside directors are responsible for providing unbiased perspectives on the board's policies.
MSc CHE, Corp CEO
Simi MBA, Independent Director
Josee CPA, Chief Officer

CardioComm Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is CardioComm Solutions a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in CardioComm Pink Sheet

CardioComm Solutions financial ratios help investors to determine whether CardioComm Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CardioComm with respect to the benefits of owning CardioComm Solutions security.